Olave's Pulmonary Clot Extends Into Training Camp; Saints Receiving Corps Faces Depth Test

Chris Olave has not been cleared for unrestricted football activity as of Wednesday's practice update, nearly five months after a pulmonary blood clot forced him to miss Week 18 against Atlanta. Saints coach Kellen Moore confirmed that Olave's workload continues to be managed throughout organized team activities, with the elite receiver still barred from full team drills. The medical restriction underscores the seriousness of a blood clot in the lung—a condition that requires deliberate clearance protocols and cannot be rushed, regardless of a player's competitive drive or contract status.

Olave was tracking toward a career-defining 2025 season before the clot emerged. He hauled in 100 receptions for 1,163 yards and nine touchdowns last season, his fourth consecutive year of 1,000-plus receiving yards. That consistency has made him one of the league's most reliable deep threats, averaging 11.6 yards per catch and commanding 10-plus targets in most games. The threat of extended absence looms larger now than it did in Week 18, when the Saints could still hope for a quick offseason recovery.

The timing compounds the concern. OTAs occur in early June; training camp opens in late July. If Olave remains unavailable through both phases, the Saints could face a genuine depth crisis at receiver heading into preseason work. Backup options like Rashid Shaheed and second-year slot receiver Tre'Quan Smith would shoulder elevated target volume in early games, driving both their ceiling and their baseline expectations upward. The Saints' play-calling design, built around Olave's route-running precision and hands, may shift toward shorter distributions and run-heavy sets until full clearance arrives.

From a prop betting angle, the uncertainty reshapes Saints passing-game architecture for the start of the 2025 season. If Olave is unavailable Week 1, Derek Carr's completion percentage likely dips as the offense adjusts to less-refined receiving weapons; conversely, if backup receivers see early volume spikes, their receiving totals become artificially inflated in those early games before Olave returns and rebalances target share. The sharper edge lies in monitoring medical timelines—if Olave clears before camp, his receiving prop ceilings stabilize at his historical 1,100-1,200 yard seasonal pace; if clearance slips into camp or beyond, season-long receiving averages for Saints pass catchers face compression, and Carr's passing yards flatten against preseason projection. Early-season Saints receiver props should be viewed as volatile and bet only once Olave's timeline is confirmed by team statement, not inferred from return-to-participation dates.

The medical reality also restrains optimism about rapid recovery. Blood clots in the lung are not minor injuries; they demand anticoagulation therapy and monitored activity ramps. Moore's Wednesday comments suggest the Saints are erring on the side of caution, which is medically appropriate but schedule-hostile. Until the team announces full clearance—not partial participation, but full—Olave's Week 1 status remains contingent.